We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current LXEO market cap is 443.5M. The company's latest EPS is USD -2.4896 and P/E is -6.68.
| Quarter End | Dec 2023 | ||
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | ||
| Operating Income | -14.97M | ||
| Net Income | -14.19M |
| Year End 31 December 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 1.66M | 654k | 0 |
| Operating Income | -50.64M | -60.51M | -68.51M |
| Net Income | -50.62M | -59.28M | -66.39M |
| Quarter End | Dec 2023 | ||
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 139.81M | ||
| Total Liabilities | 26.27M | ||
| Total Equity | 113.54M |
| Year End 31 December 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 136.86M | 97.08M | 139.81M |
| Total Liabilities | 7.45M | 25M | 26.27M |
| Total Equity | -55.6M | -112.95M | 113.54M |
| Market Cap | 443.5M |
| Price to Earnings Ratio | -6.68 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 3.65 |
| Price to Book Ratio | 3.9 |
| Dividend Yield | - |
| Shares Outstanding | 26.67M |
| Average Volume (1 week) | 113.23k |
| Average Volume (1 Month) | 130.89k |
| 52 Week Change | 75.05% |
| 52 Week High | 22.33 |
| 52 Week Low | 9.00 |
| Spread (Intraday) | 1.82 (10.76%) |
| Company Name | Lexeo Therapeutics Inc |
| Address |
|
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
